+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mycoplasma qPCR Assay Kit Market by Product Type, Technology Type, End User, Application, Sample Type - Global Forecast 2025-2030- Product Image
Mycoplasma qPCR Assay Kit Market by Product Type, Technology Type, End User, Application, Sample Type - Global Forecast 2025-2030- Product Image
New

Mycoplasma qPCR Assay Kit Market by Product Type, Technology Type, End User, Application, Sample Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6124170
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Mycoplasma qPCR Assay Kit market is experiencing a period of profound transformation driven by the confluence of technological innovation and heightened regulatory scrutiny. As laboratories seek more rapid and reliable tools to detect contamination by mycoplasma, which can severely compromise bioprocess workflows, the demand for sensitive, high-throughput assays has risen precipitously. This executive summary outlines the strategic context for stakeholders as they navigate a landscape marked by evolving performance standards, geopolitical dynamics, and diverse end-user requirements.

In recent years, advances in probe chemistries and multiplexing capabilities have broadened the applicability of qPCR assay kits beyond traditional research settings. These enhancements not only improve detection thresholds but also streamline processes for pharmaceutical developers, contract research organizations, and diagnostic laboratories. Consequently, organizations must stay apprised of emerging best practices and leverage data-driven decision making. This introduction establishes the foundational themes that recur throughout the report: technological evolution, regulatory influence, market segmentation, and actionable insights for adopting best-in-class mycoplasma detection solutions.

Navigating the Convergence of Advanced Probe Chemistries and High Throughput Multiplexing in Mycoplasma Detection

The landscape of mycoplasma qPCR assay adoption has been redefined by transformative shifts in technology and user expectations. Molecular Beacon chemistries, known for their specificity, have gained traction alongside the widely used SYBR Green dye chemistry, which offers cost-effective detection. Meanwhile, TaqMan probe chemistry continues to set benchmarks for sensitivity and reproducibility. Laboratories are now evaluating these chemistries not only on analytical performance but also on ease of integration into automated workflows.

Concurrently, there has been a discernible move from singleplex to multiplex assay kits, enabling simultaneous detection of multiple mycoplasma strains. Demand for high-throughput assay kits has accelerated, particularly formats compatible with 96- and 384-well plates, as bioprocess control applications require continuous monitoring in both upstream and downstream processing. The rising adoption of 2-plex, 4-plex, and even 5-plex kits reflects end users’ desire for streamlined throughput without sacrificing accuracy. These shifts compel vendors to continuously refine kit design, enhance user training, and ensure robust technical support.

Assessing the Ramifications of 2025 United States Import Tariffs on Critical Mycoplasma qPCR Assay Components and Supply Chains

The introduction of new United States tariffs has injected a complex variable into global supply chains for critical assay components and instrumentation. Early in 2025, increased duties on imported enzymes, polymerases, and specialized plastics began to influence manufacturers’ cost structures. As a result, assay kit producers faced higher raw material expenses, prompting some to reevaluate sourcing strategies and renegotiate long-term contracts with international suppliers.

These tariff-induced cost pressures have rippled through distribution networks, manifesting in adjusted pricing strategies for end users. Diagnostic laboratories and pharmaceutical developers, already operating under stringent budget constraints, have had to navigate a delicate balance between cost management and maintaining uncompromised analytical performance. In response, several kit manufacturers have initiated local partnerships to manufacture key reagents domestically, thereby mitigating tariff exposure. Stakeholders must monitor ongoing policy developments to optimize procurement planning and safeguard operational continuity.

Delving into Comprehensive Product, Technology, and End User Dimensions Driving the Mycoplasma qPCR Assay Kit Market

A detailed examination of product portfolios reveals that high-throughput assay kits, encompassing both 384-well and 96-well format solutions, have become the backbone of large-scale bioprocess monitoring initiatives. In contrast, singleplex assay kits remain indispensable for targeted validation and research workflows, while multiplex assay kits offering 2-plex, 4-plex, and 5-plus plex capabilities have emerged as versatile tools for labs seeking comprehensive strain coverage in a single run.

Technology type segmentation underscores that molecular beacon chemistry excels in specificity-critical applications, whereas users on constrained budgets often adopt SYBR Green dye chemistry without compromising basic detection requirements. TaqMan probe chemistry maintains its position as the gold standard for labs demanding the highest sensitivity and reproducibility.

End-user analysis indicates that academic institutions and research laboratories prioritize assay flexibility for experimental innovation, while diagnostic laboratories, hospitals, and clinics emphasize rapid turnaround and regulatory compliance. Pharmaceutical companies and contract research organizations focus on scalable, validated workflows to support large-volume bioprocess control. Veterinary clinics and veterinary testing units, witnessing increased demand for pathogen monitoring in livestock, require kits that accommodate sample types ranging from blood and urine to tissue swabs and semen.

Application-based insights reveal that bioprocess control applications span upstream monitoring protocols as well as downstream processing quality checks. In clinical diagnostics, genetic disorder screening and infectious disease testing represent critical use cases that benefit from high sensitivity. Research settings leverage the kits for exploratory studies, and veterinary testing units demand robust performance across diverse sample matrices.

Uncovering Distinct Regional Dynamics Shaping Demand and Innovation in Mycoplasma qPCR Assay Kits Across Global Markets

Regional dynamics in the Americas highlight a mature market characterized by strong adoption of automated high-throughput workflows and a supportive regulatory environment that emphasizes contamination control in biopharmaceutical manufacturing. North American laboratories benefit from advanced infrastructure investment, fostering rapid uptake of novel assay innovations.

In Europe, regulatory frameworks continue to evolve toward harmonization, promoting unified quality standards for mycoplasma testing across member states and adjacent markets in the Middle East and Africa. This alignment encourages cross-border collaborations and opens new opportunities for standardized assay kit deployments in growing biotech hubs.

The Asia-Pacific region has emerged as a high-growth arena, fueled by expanding biopharmaceutical production, rising healthcare expenditure, and government initiatives supporting local reagent manufacturing. Countries in this region are increasingly establishing domestic supply chains to minimize reliance on imports, thereby strengthening resilience against geopolitical uncertainties.

Examining the Strategic Partnerships, Technological Leadership, and Service Models of Leading Mycoplasma qPCR Assay Kit Providers

Key players in the market have distinguished themselves through a combination of technological leadership and strategic collaborations. Several established life sciences companies have augmented their product portfolios via targeted acquisitions of specialized molecular diagnostics firms, thereby enhancing their multiplexing and high-throughput capabilities.

Innovative startups have disrupted traditional models by introducing subscription-based reagent supply programs, paired with digital assay tracking platforms that offer real-time performance metrics. These initiatives have resonated with contract research organizations and biopharma manufacturers seeking transparent cost structures and predictive procurement.

Strategic alliances with academic research centers and veterinary institutions have enabled leading assay kit vendors to validate novel chemistries under real-world conditions, accelerating regulatory submissions and expanding user confidence. Continuous investment in global technical support networks and user training programs has further solidified incumbent competitiveness.

Guiding Market Leaders Toward Strategic Technological Investments, Resilient Supply Chains, and Collaborative Ecosystem Engagements

Industry leaders should prioritize investment in next-generation probe chemistries that deliver enhanced sensitivity while reducing cycle times. Accelerating the transition to multiplex formats with intuitive data analysis software will address the growing need for streamlined workflows and consolidated reporting.

Developing flexible manufacturing models, including localized reagent production and modular kit assembly, can mitigate supply chain risks associated with import tariffs and logistics disruptions. Engaging in proactive policy dialogues with regulatory agencies will ensure emerging compliance requirements are anticipated rather than reacted to, safeguarding uninterrupted product availability.

Cultivating deeper collaborations with end users through co-development programs and training workshops will not only accelerate product iteration cycles but also build brand loyalty. Finally, embracing data-driven service offerings-such as real-time assay performance dashboards-will differentiate providers in a competitive landscape and foster transparency from procurement through validation.

Illuminating Research Foundations Through Rigorous Primary Interviews, Secondary Data Analysis, and Strategic Analytical Frameworks

This report synthesizes insights from a mixed-methods research approach combining primary interviews and secondary data analysis. Primary research included in-depth discussions with decision-makers at diagnostic laboratories, contract research organizations, pharmaceutical companies, and veterinary clinics to capture firsthand perspectives on assay performance, workflow integration, and procurement challenges.

Secondary research drew upon peer-reviewed publications, industry white papers, and regulatory submissions to validate assay chemistries and performance benchmarks. Data on regional trade policies and tariff schedules were cross-referenced with public domain government databases to quantify the impact of new duties on assay component costs.

Analytical frameworks such as SWOT and PESTEL were applied to evaluate market drivers, restraints, and emergent opportunities. Segmentation mapping was conducted to ensure a cohesive understanding of product type, technology, application, end user, and sample type influences across global regions. Rigorous triangulation methods were employed to ensure findings are both reliable and actionable.

Converging Technological Innovation and Supply Chain Resilience to Define the Next Era of Mycoplasma Detection Excellence

The Mycoplasma qPCR Assay Kit market is at a strategic inflection point characterized by rapid technological refinement and shifting global trade dynamics. Stakeholders must navigate an increasingly complex environment that demands both analytical rigor and operational agility. Emerging probe chemistries, combined with high-throughput multiplexing, represent the most immediate avenues for performance enhancement, while supply chain resilience will hinge on flexible manufacturing partnerships and proactive regulatory engagement.

By integrating the insights presented in this report-ranging from detailed segmentation analyses to regional and corporate strategies-decision-makers can chart a course that balances innovation, compliance, and cost efficiency. The future of contamination control in bioprocessing, clinical diagnostics, research, and veterinary applications will be shaped by those organizations that anticipate shifts in market demands, invest strategically in technology, and cultivate collaborative ecosystems.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • High Throughput Assay Kits
      • 384-Well Format Kits
      • 96-Well Format Kits
    • Multiplex Assay Kits
      • 2-Plex Kits
      • 4-Plex Kits
      • 5+ Plex Kits
    • Singleplex Assay Kits
  • Technology Type
    • Molecular Beacon Chemistry
    • SYBR Green Dye Chemistry
    • TaqMan Probe Chemistry
  • End User
    • Academic Institutions
    • Contract Research Organizations
    • Diagnostic Laboratories
    • Hospitals And Clinics
    • Pharmaceutical Companies
    • Research Laboratories
    • Veterinary Clinics
  • Application
    • Bioprocess Control
      • Downstream Processing
      • Upstream Monitoring
    • Clinical Diagnostics
      • Genetic Disorder Screening
      • Infectious Disease Testing
    • Research
    • Veterinary Testing
  • Sample Type
    • Blood Samples
    • Cell Culture Supernatant
    • Semen Samples
    • Swab Samples
    • Tissue Samples
    • Urine Samples
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG
  • Qiagen N.V.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • bioMérieux S.A.
  • Takara Bio Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of automated high-throughput qPCR platforms for mycoplasma detection in biopharma manufacturing environments
5.2. Emergence of multiplex mycoplasma qPCR assays enabling simultaneous detection of multiple contaminants in cell culture workflows
5.3. Integration of digital PCR and next-generation qPCR assays for enhanced sensitivity in detecting low-level mycoplasma contamination
5.4. Growing demand for CE-IVD and FDA-approved qPCR mycoplasma test kits in regulated biomanufacturing and cell therapy sectors
5.5. Development of smartphone-compatible and cloud-connected qPCR devices for real-time mycoplasma monitoring in research labs
5.6. Advent of lyophilized mycoplasma qPCR assay reagents enhancing kit stability and reducing cold chain dependency in remote facilities
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Mycoplasma qPCR Assay Kit Market, by Product Type
8.1. Introduction
8.2. High Throughput Assay Kits
8.2.1. 384-Well Format Kits
8.2.2. 96-Well Format Kits
8.3. Multiplex Assay Kits
8.3.1. 2-Plex Kits
8.3.2. 4-Plex Kits
8.3.3. 5+ Plex Kits
8.4. Singleplex Assay Kits
9. Mycoplasma qPCR Assay Kit Market, by Technology Type
9.1. Introduction
9.2. Molecular Beacon Chemistry
9.3. SYBR Green Dye Chemistry
9.4. TaqMan Probe Chemistry
10. Mycoplasma qPCR Assay Kit Market, by End User
10.1. Introduction
10.2. Academic Institutions
10.3. Contract Research Organizations
10.4. Diagnostic Laboratories
10.5. Hospitals and Clinics
10.6. Pharmaceutical Companies
10.7. Research Laboratories
10.8. Veterinary Clinics
11. Mycoplasma qPCR Assay Kit Market, by Application
11.1. Introduction
11.2. Bioprocess Control
11.2.1. Downstream Processing
11.2.2. Upstream Monitoring
11.3. Clinical Diagnostics
11.3.1. Genetic Disorder Screening
11.3.2. Infectious Disease Testing
11.4. Research
11.5. Veterinary Testing
12. Mycoplasma qPCR Assay Kit Market, by Sample Type
12.1. Introduction
12.2. Blood Samples
12.3. Cell Culture Supernatant
12.4. Semen Samples
12.5. Swab Samples
12.6. Tissue Samples
12.7. Urine Samples
13. Americas Mycoplasma qPCR Assay Kit Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Mycoplasma qPCR Assay Kit Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Mycoplasma qPCR Assay Kit Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. F. Hoffmann-La Roche AG
16.3.3. Qiagen N.V.
16.3.4. Merck KGaA
16.3.5. Bio-Rad Laboratories, Inc.
16.3.6. Agilent Technologies, Inc.
16.3.7. PerkinElmer, Inc.
16.3.8. Promega Corporation
16.3.9. BioMérieux S.A.
16.3.10. Takara Bio Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MYCOPLASMA QPCR ASSAY KIT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MYCOPLASMA QPCR ASSAY KIT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MYCOPLASMA QPCR ASSAY KIT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MYCOPLASMA QPCR ASSAY KIT MARKET: RESEARCHAI
FIGURE 26. MYCOPLASMA QPCR ASSAY KIT MARKET: RESEARCHSTATISTICS
FIGURE 27. MYCOPLASMA QPCR ASSAY KIT MARKET: RESEARCHCONTACTS
FIGURE 28. MYCOPLASMA QPCR ASSAY KIT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MYCOPLASMA QPCR ASSAY KIT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY 384-WELL FORMAT KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY 384-WELL FORMAT KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY 96-WELL FORMAT KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY 96-WELL FORMAT KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY 2-PLEX KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY 2-PLEX KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY 4-PLEX KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY 4-PLEX KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY 5+ PLEX KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY 5+ PLEX KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SINGLEPLEX ASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SINGLEPLEX ASSAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MOLECULAR BEACON CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MOLECULAR BEACON CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SYBR GREEN DYE CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SYBR GREEN DYE CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TAQMAN PROBE CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TAQMAN PROBE CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY UPSTREAM MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY UPSTREAM MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY GENETIC DISORDER SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY GENETIC DISORDER SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY VETERINARY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY VETERINARY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CELL CULTURE SUPERNATANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CELL CULTURE SUPERNATANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SEMEN SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SEMEN SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SWAB SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SWAB SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY URINE SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 134. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 135. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 136. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 137. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 138. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 139. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2018-2024 (USD MILLION)
TABLE 144. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2025-2030 (USD MILLION)
TABLE 145. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 146. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 147. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 148. CANADA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2018-2024 (USD MILLION)
TABLE 162. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2025-2030 (USD MILLION)
TABLE 163. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 241. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 244. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 245. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 246. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 247. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 248. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 249. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2018-2024 (USD MILLION)
TABLE 254. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2025-2030 (USD MILLION)
TABLE 255. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 256. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 257. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 258. GERMANY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 259. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 262. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 263. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 264. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 265. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 266. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 267. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2018-2024 (USD MILLION)
TABLE 272. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2025-2030 (USD MILLION)
TABLE 273. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 274. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 275. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 276. FRANCE MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 295. ITALY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. ITALY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. ITALY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 298. ITALY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY HIGH THROUGHPUT ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 299. ITALY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 300. ITALY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY MULTIPLEX ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 301. ITALY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 302. ITALY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 303. ITALY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. ITALY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. ITALY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. ITALY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. ITALY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2018-2024 (USD MILLION)
TABLE 308. ITALY MYCOPLASMA QPCR ASSAY KIT MARKET SIZE, BY BIOPROCESS CONTROL, 2025-2030 (USD MILLION)
TABLE 309. ITALY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Mycoplasma qPCR Assay Kit market report include:
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG
  • Qiagen N.V.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • bioMérieux S.A.
  • Takara Bio Inc.

Related Topics

Related Reports

qPCR Assay Kit Market by Detection Chemistry (Probe Based Assays, Sybr Green Assays), Application (Agricultural Testing, Clinical Diagnostics, Drug Discovery), End User, Pcr Mode - Global Forecast 2025-2030 - Product Image

qPCR Assay Kit Market by Detection Chemistry (Probe Based Assays, Sybr Green Assays), Application (Agricultural Testing, Clinical Diagnostics, Drug Discovery), End User, Pcr Mode - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
One Step RT-qPCR Kits Market by Type (Dye Based, Probe Based), Application (Cancer Screening, Drug Discovery, Environmental Testing), End User, Target Molecule, Kit Format - Global Forecast 2025-2030 - Product Image

One Step RT-qPCR Kits Market by Type (Dye Based, Probe Based), Application (Cancer Screening, Drug Discovery, Environmental Testing), End User, Target Molecule, Kit Format - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
dPCR & qPCR Market by Product Type (Consumables, Instruments, Software And Services), Technology Type (Dpcr, Qpcr), Application, End-User - Global Forecast 2025-2030 - Product Image

dPCR & qPCR Market by Product Type (Consumables, Instruments, Software And Services), Technology Type (Dpcr, Qpcr), Application, End-User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
qPCR Reagents Market by Product Type (Enzymes, Fluorescent Dyes, Primers), Mechanism (Dye Based, Probe Based), Technology, Throughput, Application, End User - Global Forecast 2025-2030 - Product Image

qPCR Reagents Market by Product Type (Enzymes, Fluorescent Dyes, Primers), Mechanism (Dye Based, Probe Based), Technology, Throughput, Application, End User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Targeted Genome Analysis Kits Market by Sequencing Kits (Next Generation Sequencing Kits, Sanger Sequencing Kits), Qpcr Kits (Dye Qpcr Kits, Probe Qpcr Kits), Microarray Kits, Hybridization Kits - Global Forecast 2025-2030 - Product Image

Targeted Genome Analysis Kits Market by Sequencing Kits (Next Generation Sequencing Kits, Sanger Sequencing Kits), Qpcr Kits (Dye Qpcr Kits, Probe Qpcr Kits), Microarray Kits, Hybridization Kits - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.